Acute triangles in triangulations on the plane with minimum degree at least 4

AbstractIn this paper, we show that every maximal plane graph with minimum degree at least 4 and m finite faces other than an octahedron can be drawn in the plane so that at least (m+3)/2 faces are acute triangles. Moreover, this bound is sharp

Study on improvement technique of coastal marine sediments using granulated coal ash

広島大学(Hiroshima University)博士(工学)Doctor of Engineeringdoctora

Prevention of Hepatocellular Carcinoma Development Associated with Chronic Hepatitis by Anti-Fas Ligand Antibody Therapy

A persistent immune response to hepatitis viruses is a well-recognized risk factor for hepatocellular carcinoma. However, the molecular and cellular basis for the procarcinogenic potential of the immune response is not well defined. Here, using a unique animal model of chronic hepatitis that induces hepatocellular carcinogenesis, we demonstrate that neutralization of the activity of Fas ligand prevented hepatocyte apoptosis, proliferation, liver inflammation, and the eventual development of hepatocellular carcinoma. The results indicate that Fas ligand is involved not only in direct hepatocyte killing but also in the process of inflammation and hepatocellular carcinogenesis in chronic hepatitis. This is the first demonstration that amelioration of chronic inflammation by some treatment actually caused reduction of cancer development

Evaluation of transporter-mediated hepatobiliary transport of newly developed ¹⁸F-labeled pitavastatin derivative, PTV-F1, in rats by PET imaging

Quantitative evaluations of the functions of uptake and efflux transporters directly in vivo is desired to understand an efficient hepatobiliary transport of substrate drugs. Pitavastatin is a substrate of organic anion transporting polypeptides (OATPs) and canalicular efflux transporters; thus, it can be a suitable probe for positron-emission tomography (PET) imaging of hepatic transporter functions. To characterize the performance of [¹⁸F]PTV-F1, an analogue of pitavastatin, we investigated the impact of rifampicin (a typical OATP inhibitor) coadministration or Bcrp (breast cancer resistance protein) knockout on [¹⁸F]PTV-F1 hepatic uptake and efflux in rats by PET imaging. After intravenous administration, [¹⁸F]PTV-F1 selectively accumulated in the liver, and the radioactivity detected in plasma, liver, and bile mainly derived from the parent PTV-F1 during the PET study (∼40 min). Coadministration of rifampicin largely decreased the hepatic uptake of [¹⁸F]PTV-F1 by 73%. Because of its lower clearance in rats, [¹⁸F]PTV-F1 is more sensitive for monitoring changes in hepatic OATP1B function that other previously reported OATP1B PET probes. Rifampicin coadministration also significantly decreased the biliary excretion of radioactivity by 65%. Bcrp knockout did not show a significant impact on its biliary excretion.[¹⁸F]PTV-F1 enables quantitative analysis of the hepatobiliary transport system for organic anions

Formation of globular clusters induced by external ultraviolet radiation

We present a novel scenario for globular cluster (GC) formation, where the ultraviolet (UV) background radiation effectively works so as to produce compact star clusters. Here, we explore the formation of GCs in UV radiation fields. For this purpose, we calculate baryon and dark matter (DM) dynamics in spherical symmetry, incorporating the self-shielding effects by solving the radiative transfer of UV radiation. In addition, we prescribe the star formation in cooled gas components and pursue the dynamics of formed stars. As a result, we find that the evolution of subgalactic objects in UV background radiation are separated into three types, that is, (1) prompt star formation, where less massive clouds ~10^{5-8} M_sun are promptly self-shielded and undergo star formation, (2) delayed star formation, where photoionized massive clouds >10^8 M_sun collapse despite high thermal pressure and are eventually self-shielded to form stars in a delayed fashion, and (3) supersonic infall, where photoionized less massive clouds ~10^{5-8} M_sun contract with supersonic infall velocity and are self-shielded when a compact core forms. In particular, the type (3) is a novel type found in the present simulations, and eventually produces a very compact star cluster. The resultant mass-to-light ratios, half-mass radii, and velocity dispersions for the three types are compared to the observations of GCs, dwarf spheroidals (dSphs), and ultra-compact dwarfs (UCDs). It turns out that the properties of star clusters resulting from supersonic infall match well with those of observed GCs, whereas the other two types are distinct from GCs. Hence, we conclude that supersonic infall in a UV background is a promising mechanism to form GCs.Comment: 11pages, 9figures, accepted for publication in MNRAS, a few typos are fixe

Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

The "Guideline on the Use of New Anticancer Drugs for the Treatment of Hepatocellular Carcinoma" was prepared by the Study Group on New Liver Cancer Therapies established by the "Research Project on Emergency Measures to Overcome Hepatitis" under the auspices of the Health and Labour Sciences Research Grant. The Guideline brings together data collected by the Study Group on the use and incidence of adverse events in 264 patients with advanced hepatocellular carcinoma (HCC) treated using sorafenib and in 535 patients with advanced HCC treated using miriplatin at 16 participating institutions up until 22 December 2010, as well as referring to the published studies, academic presentations, and reports from the private sector. The aim of this Guideline is to facilitate understanding and current thinking regarding the proper usage of new anticancer drugs towards actual use in therapy. In terms of the format, the Guideline presents "clinical questions" on issues pertaining to medical care, makes "recommendations" on diagnosis and treatment in response to each of these clinical questions, and provides a rationale for these recommendations in the form of "scientific statements". © 2012 The Japan Society of Hepatology